Huairong Tang

578 total citations
23 papers, 380 citations indexed

About

Huairong Tang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Huairong Tang has authored 23 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Huairong Tang's work include Lung Cancer Treatments and Mutations (5 papers), Frailty in Older Adults (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Huairong Tang is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Frailty in Older Adults (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). Huairong Tang collaborates with scholars based in China, United States and Hong Kong. Huairong Tang's co-authors include Ming Yang, Jiaojiao Jiang, Yun Zuo, Ying Liu, Yan Huang, Jing Lü, Ting Bao, Weimin Li, Guiyi Ji and Dan Liu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Medicine.

In The Last Decade

Huairong Tang

23 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huairong Tang China 12 133 86 77 70 57 23 380
Kenta Kambara Japan 13 107 0.8× 70 0.8× 62 0.8× 160 2.3× 74 1.3× 35 448
Seisuke Okazawa Japan 13 92 0.7× 65 0.8× 62 0.8× 136 1.9× 106 1.9× 44 456
Jayan George United Kingdom 6 125 0.9× 81 0.9× 48 0.6× 39 0.6× 22 0.4× 24 338
Minehiko Inomata Japan 14 91 0.7× 84 1.0× 62 0.8× 170 2.4× 67 1.2× 54 457
Xiaoding Shen China 8 215 1.6× 38 0.4× 114 1.5× 31 0.4× 39 0.7× 11 354
Junichi Kitagawa Japan 11 115 0.9× 79 0.9× 41 0.5× 35 0.5× 31 0.5× 34 383
Tomoya Kanai Japan 12 195 1.5× 82 1.0× 54 0.7× 22 0.3× 106 1.9× 27 407
Tenglong Tang China 10 70 0.5× 75 0.9× 42 0.5× 65 0.9× 93 1.6× 20 474
Masaya Tsuda Japan 14 59 0.4× 167 1.9× 16 0.2× 51 0.7× 47 0.8× 32 425
Min Deng China 12 35 0.3× 103 1.2× 13 0.2× 75 1.1× 51 0.9× 28 337

Countries citing papers authored by Huairong Tang

Since Specialization
Citations

This map shows the geographic impact of Huairong Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huairong Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huairong Tang more than expected).

Fields of papers citing papers by Huairong Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huairong Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huairong Tang. The network helps show where Huairong Tang may publish in the future.

Co-authorship network of co-authors of Huairong Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Huairong Tang. A scholar is included among the top collaborators of Huairong Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huairong Tang. Huairong Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bao, Ting, Bingqing Liu, Ruicen Li, et al.. (2024). LDCT screening results among eligible and ineligible screening candidates in preventive health check-ups population: a real world study in West China. Scientific Reports. 14(1). 4848–4848. 1 indexed citations
3.
Gao, Wei, Yanwen Jin, Yan Huang, & Huairong Tang. (2022). Discordantly high glycated hemoglobin might assist in diagnosing α‐thalassemia, but not diabetes: A case report. Journal of Diabetes Investigation. 13(9). 1633–1635. 1 indexed citations
4.
Gao, Wei, Yanwen Jin, Minjin Wang, Yan Huang, & Huairong Tang. (2022). Case Report: Abnormally Low Glycosylated Hemoglobin A1c Caused by Clinically Silent Rare β-Thalassemia in a Tujia Chinese Woman. Frontiers in Endocrinology. 13. 878680–878680. 3 indexed citations
5.
Ji, Guiyi, Ting Bao, Zhenzhen Li, et al.. (2021). Current lung cancer screening guidelines may miss high-risk population: a real-world study. BMC Cancer. 21(1). 50–50. 34 indexed citations
6.
Han, Ning, Libo Yan, & Huairong Tang. (2021). [Clinical significance and management strategies of low-level viremia during the treatment of chronic hepatitis B].. PubMed. 29(12). 1139–1143. 1 indexed citations
7.
Li, Ruicen, et al.. (2020). Correlation between prostate‑specific antigen and four renal function‑associated parameters in different ethnicities in southwest China. Experimental and Therapeutic Medicine. 20(6). 143–143. 1 indexed citations
9.
Bao, Ting, Zhiye Ying, L. Gong, et al.. (2020). Association between Serum Uric Acid and Nonalcoholic Fatty Liver Disease in Nonobese Postmenopausal Women: A Cross-sectional Study. Scientific Reports. 10(1). 10072–10072. 23 indexed citations
10.
Zhang, Li, Dan Pu, Dan Liu, et al.. (2019). Identification and validation of novel circulating biomarkers for early diagnosis of lung cancer. Lung Cancer. 135. 130–137. 15 indexed citations
11.
Yang, Ming, Ying Liu, Yun Zuo, & Huairong Tang. (2019). Sarcopenia for predicting falls and hospitalization in community-dwelling older adults: EWGSOP versus EWGSOP2. Scientific Reports. 9(1). 17636–17636. 57 indexed citations
12.
Li, Ruicen, et al.. (2019). The risk of stroke and associated risk factors in a health examination population. Medicine. 98(40). e17218–e17218. 14 indexed citations
13.
Yang, Ming, et al.. (2018). Comparison of four sarcopenia screening tools in nursing home residents. Aging Clinical and Experimental Research. 31(10). 1481–1489. 44 indexed citations
14.
Cao, Hongshuai, et al.. (2018). Erosion of mold-steel surface oxidation and nitriding layers due to a die-casting aluminum alloy. Materiali in tehnologije. 52(5). 619–624. 1 indexed citations
15.
Xu, Wang‐Dong, et al.. (2017). Analysis of blood glucose distribution characteristics in a health examination population in Chengdu (2007–2015). Medicine. 96(49). e8765–e8765. 5 indexed citations
16.
Liu, Lei, Ying He, Ge Ge, et al.. (2017). Lactate dehydrogenase and creatine kinase as poor prognostic factors in lung cancer: A retrospective observational study. PLoS ONE. 12(8). e0182168–e0182168. 27 indexed citations
17.
Chen, Bojiang, Lan Yang, Yuncui Gan, et al.. (2017). Hyperphosphorylation of RPS6KB1, rather than overexpression, predicts worse prognosis in non-small cell lung cancer patients. PLoS ONE. 12(8). e0182891–e0182891. 22 indexed citations
18.
Zhou, Le, et al.. (2016). Pulmonary sclerosing hemangioma with a rare symptom: A case report and review of the literature. Molecular and Clinical Oncology. 6(2). 221–224. 7 indexed citations
19.
Tang, Huairong, et al.. (2014). [Helicobacter pylori infection and associated risk factors in Chengdu].. PubMed. 45(5). 823–6. 4 indexed citations
20.
Tang, Huairong, et al.. (2014). In vivo osteoprotegerin gene therapy preventing bone loss induced by periodontitis. Journal of Periodontal Research. 50(4). 434–443. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026